About Spear Bio
Spear Bio is a company based in Boston (United States) founded in 2021 by Feng Xuan and Peng Yin.. Spear Bio has raised $48.96 million across 4 funding rounds from investors including Bio-Techne, Foresite Capital and Maverick Ventures. Spear Bio offers products and services including SPEAR Technology and Workflow & Automation. Spear Bio operates in a competitive market with competitors including Abingdon Health, Olink, US BioTek Laboratories, Eclipse Bio and Virtue Diagnostics, among others.
- Headquarter Boston, United States
- Founders Feng Xuan, Peng Yin
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spear Bio Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48.96 M (USD)
in 4 rounds
-
Latest Funding Round
$45 M (USD), Series A
Jul 23, 2024
-
Investors
Bio-Techne
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spear Bio
Spear Bio offers a comprehensive portfolio of products and services, including SPEAR Technology and Workflow & Automation. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables ultra-sensitive biomarker detection from minimal samples with high accuracy.
Automates immunoassay processes for efficient research and development tasks.
Unlock access to complete
Unlock access to complete
Funding Insights of Spear Bio
Spear Bio has successfully raised a total of $48.96M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $45 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $45.0M
-
First Round
First Round
(14 Oct 2021)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series A - Spear Bio | Valuation | Foresite Capital , Bio-Techne | |
| Nov, 2023 | Amount | Seed - Spear Bio | Valuation | Sequoia China Seed Fund , CDH | |
| Oct, 2022 | Amount | Seed - Spear Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spear Bio
Spear Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Bio-Techne, Foresite Capital and Maverick Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Early-stage tech and life-sciences firms are funded across the US.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Yongjin Group
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spear Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spear Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spear Bio Comparisons
Competitors of Spear Bio
Spear Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, US BioTek Laboratories, Eclipse Bio and Virtue Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of immunoassays for diagnostic purposes
|
|
| domain | founded_year | HQ Location |
Provider of products and services for human protein biomarker research and development
|
|
| domain | founded_year | HQ Location |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| domain | founded_year | HQ Location |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| domain | founded_year | HQ Location |
An in vitro assay platform is provided for diagnostic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spear Bio
Frequently Asked Questions about Spear Bio
When was Spear Bio founded?
Spear Bio was founded in 2021.
Where is Spear Bio located?
Spear Bio is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Spear Bio a funded company?
Spear Bio is a funded company, having raised a total of $48.96M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.39M, raised on Oct 14, 2021.
What does Spear Bio do?
Spear Bio was founded in 2021 in Boston, United States, within the biotechnology sector focused on diagnostics and research tools. Ultrasensitive immunoassays and proteomics platforms are developed by the company to detect protein biomarkers. TNAB-sure SARS-CoV-2 neutralizing antibody test kits are offered for antibody detection in small samples. A reagent-based platform is provided for ultrasensitive protein detection in low-volume samples, supporting applications in research and clinical diagnostics.
Who are the top competitors of Spear Bio?
Spear Bio's top competitors include Abingdon Health, Eclipse Bio and Olink.
What products or services does Spear Bio offer?
Spear Bio offers SPEAR Technology and Workflow & Automation.
Who are Spear Bio's investors?
Spear Bio has 7 investors. Key investors include Bio-Techne, Foresite Capital, Maverick Ventures, Yonjin Capital, and CDH.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.